(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

KLICKMER

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

KLICKMER

ST13

US500000079311991

Classe

1, 5

Pedido

79311991

Registro

6720843

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

35

Atualização mais recente

19/11/2024

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

05/02/2021

Data de registro

24/05/2022

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/05/2022

Última transação

19/11/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

DK

Examinador

VERHOSEK, WILLIAM

Unidade examinadora

M50

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

I. A. (pessoa física)

Representantes

Miriam D. Trudell Davis Graham & Stubbs LLP

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals used in diagnosticsindustry and scienceother than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagentsmonoclonal antibodiesreagentsdiagnostic agentscontrol reagentsDNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapycancer vaccinesborrelia vaccinesTB-vaccinesHIV-vaccinesCMV-vaccines and other vaccinesfor analysis for research purposes of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor analysis for research purposes of infectious diseasesautoimmunity and for use in connection with toxicological studies and research in relation to transplantationimmune monitoringvaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Classe 5

Preparations for pharmaceutical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccinesimmunotherapeutics and cellular therapiesincluding cancer vaccines and immunotherapeuticsborrelia vaccinesTB-vaccinesHIV-vaccines and CMV-vaccinesT-cell therapiesfor use in connection with cancer therapy and other medical therapiesfor analysis and treatment of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor infectious diseasesfor use in connection with medical procedures and diagnosistransplantationimmune monitoringvaccines and T-cell monitoring

Publicações

Histórico de despachos e eventos da marca no USPTO.

35 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/11/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/11/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/11/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

14/04/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

14/04/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

14/04/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

14/04/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

14/04/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

14/04/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/04/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/10/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/09/2022

FIMP

FINAL DISPOSITION PROCESSED

09/09/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

24/08/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

24/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

24/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

22/02/2022

PUBO

PUBLISHED FOR OPPOSITION

22/02/2022

GPNX

NOTIFICATION PROCESSED BY IB

20/02/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/02/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/01/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/01/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/01/2022

RFNT

REFUSAL PROCESSED BY IB

04/10/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

13/09/2021

RFRR

REFUSAL PROCESSED BY MPU

13/09/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/09/2021

CNRT

NON-FINAL ACTION WRITTEN

31/08/2021

DOCK

ASSIGNED TO EXAMINER

30/08/2021

MAFR

APPLICATION FILING RECEIPT MAILED

08/06/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/06/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

27/05/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace KLICKMER ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.